RVTY Revvity
- Official Name: REVVITY, INC.
- Headquarters: 77 4Th Avenue, WALTHAM, MA, 02451 US
- CEO: Prahlad Singh
- Website: revvity.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1R | Lost by 0.399 | (2.333) - (1.934) | ||
| 2025-07-16 | 1R | Lost by 2.527 | (0.620) - 1.907 | ||
| 2025-07-18 | 1 | Lost by 6.322 | (6.139) - 0.183 | ||
| 2025-07-25 | 2 | Won by 6.741 | 11.009 - 4.268 | ||
| 2025-08-01 | 3 | Lost by 1.971 | (6.402) - (4.431) | ||
| 2025-08-07 | 1R | Won by 0.211 | 0.725 - 0.514 | ||
| 2025-08-08 | 4 | Lost by 8.671 | (1.067) - 7.604 | ||
| 2025-08-15 | 5 | Won by 2.099 | 4.418 - 2.319 | ||
| 2025-08-21 | 2R | Lost by 0.458 | (1.831) - (1.373) | ||
| 2025-08-22 | 6 | Won by 2.256 | 3.260 - 1.004 | ||
| 2025-08-29 | 7 | Lost by 0.087 | (4.489) - (4.402) | ||
| 2025-09-05 | 8 | Lost by 2.068 | (4.422) - (2.354) | ||
| 2025-09-12 | 9 | Lost by 2.595 | (4.472) - (1.877) | ||
| 2025-09-19 | 10 | Won by 6.184 | 4.597 - (1.587) | ||
| 2025-09-26 | 11 | Lost by 13.612 | (2.833) - 10.779 | ||
| 2025-10-03 | 12 | Won by 6.987 | 11.984 - 4.997 | ||
| 2025-10-10 | 13 | Lost by 6.763 | (6.263) - 0.500 | ||
| 2025-10-17 | 14 | Lost by 3.041 | 5.651 - 8.692 | ||
| 2025-10-24 | 15 | Won by 5.138 | 5.949 - 0.811 |
Latest News

1 Cash-Producing Stock to Own for Decades and 2 We Question
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate...

Revvity (RVTY), What Is Drawing Fresh Attention Now?
Revvity (RVTY) is back on investor calendars after announcing third quarter 2026 results are due on 3 November, with earnings per share expected to be...

How To Invest In AI Drug Discovery
While AI can design prospective drug molecules in seconds, validating whether they work still depends on slow physical wet-lab testing and custom test...

Revvity (RVTY) Stock Could Be 12% Stretched On Cash Flow
Revvity has delivered a strong share price run over the past year, and the key issue now is whether that market enthusiasm lines up with the cash the ...

Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings
DGX heads into Q3 earnings with expected revenue and EPS growth, fueled by strong clinical demand, advanced diagnostics and operational efficiencies.

3 Hyped Up Stocks We Think Twice About
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business executi...

Here's How Much $100 Invested In Revvity 15 Years Ago Would Be Worth Today
Revvity (NYSE:RVTY) has outperformed the market over the past 15 years by 1.91% on an annualized basis producing an average annual return of 15.11%. C...

Thermo Fisher to Report Q3 Earnings: What's in the Cards?
TMO gears up for Q3 earnings, with revenue and EPS growth expected amid strong bioproduction demand, product innovations and clinical research strengt...

Revvity to Present at Upcoming Investor Conferences
WALTHAM, Mass., October 13, 2026--Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:
TD Cowen Maintains Buy on Revvity, Raises Price Target to $175
TD Cowen analyst Dan Brennan maintains Revvity (NYSE:RVTY) with a Buy and raises the price target from $130 to $175.